|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/00 | |
| A61K 31/7064 | |||
| A61K 39/395 | |||
| A61K 47/48 | |||
| C07K 16/28 |
| (11) | Patento numeris | 2211885 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08837451.7 |
| Europos patento paraiškos padavimo data | 2008-10-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-08-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-07-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2008/079224 |
| Data | 2008-10-08 |
| (87) | Numeris | WO 2009/048967 |
| Data | 2009-04-16 |
| (30) | Numeris | Data | Šalis |
| 979594 P | 2007-10-12 | US | |
| 27668 P | 2008-02-11 | US | |
| 40641 P | 2008-03-28 | US |
| (72) |
OFLAZOGLU, Ezogelin, US
SIEVERS, Eric, US
GERBER, Hans-Peter, US
|
| (73) |
Seattle Genetics, Inc.,
21823 30th Drive, S.E., Bothell, WA 98021,
US
|
| (54) | COMBINATION THERAPY WITH ANTIBODY-DRUG CONJUGATES |
| COMBINATION THERAPY WITH ANTIBODY-DRUG CONJUGATES |